ProfileGDS4132 / 210289_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 33% 36% 36% 42% 41% 33% 38% 27% 34% 31% 23% 31% 34% 30% 25% 22% 35% 27% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10186.882934
GSM201543Muscle PCOS pioglitazone 12173.704833
GSM201544Muscle PCOS pioglitazone 16194.560736
GSM201545Muscle PCOS pioglitazone 201100.30336
GSM201829Muscle PCOS pioglitazone 231115.3442
GSM201830Muscle PCOS pioglitazon 251111.31441
GSM201831Muscle PCOS pioglitazone 27180.921933
GSM201832Muscle PCOS pioglitazone 3196.465438
GSM201833Muscle PCOS pioglitazone 4161.140527
GSM201834Muscle PCOS pioglitazone 8182.024634
GSM201835Muscle PCOS after pioglitazone 10263.661131
GSM201836Muscle PCOS after pioglitazone 12243.882423
GSM201837Muscle PCOS after pioglitazone 16262.420331
GSM201838Muscle PCOS after pioglitazone 20277.392234
GSM201839Muscle PCOS after pioglitazone 23267.538130
GSM201840Muscle PCOS after pioglitazone 25255.43625
GSM201841Muscle PCOS after pioglitazone 27239.633322
GSM201842Muscle PCOS after pioglitazone 3271.157435
GSM201843Muscle PCOS after pioglitazone 4262.524927
GSM201844Muscle PCOS after pioglitazone 8262.939828